Legal & General Group
EPIX

Legal & General Group’s ESSA Pharma EPIX Stock Holding History

Legal & General Group’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,124
Closed -$38K – 3563
2022
Q1 		$38K Hold
6,124
– – ﹤0.01% 3056
2021
Q4 		$87K Buy
6,124
+1,003
+20% +$11.2K ﹤0.01% 2933
2021
Q3 		$41K Buy
5,121
+4,197
+454% +$66.7K ﹤0.01% 3029
2021
Q2 		$26K Buy
+924
New +$26.9K ﹤0.01% 3191

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Legal & General Group's EPIX Position: Q2 2022 in Review

Legal & General Group sold out of ESSA Pharma (EPIX) in Q2 2022, closing a stake of 6,124 shares — an estimated $38K sold.

Legal & General Group first reported a position in EPIX in Q2 2021 and held it in 4 quarters. The position peaked at $87K in Q4 2021. 59 funds tracked by Wall St. Rank hold EPIX as of Q2 2022.

  • Legal & General Group reported no remaining ESSA Pharma position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 6,124 ESSA Pharma shares in Q2 2022, an estimated $38K.
  • Legal & General Group first reported a position in ESSA Pharma in Q2 2021 and held it in 4 quarters.
  • Legal & General Group's ESSA Pharma position peaked at $87K in Q4 2021.
  • 59 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.